Cargando…

Targeting hypoxic tumor microenvironment in pancreatic cancer

Attributable to its late diagnosis, early metastasis, and poor prognosis, pancreatic cancer remains one of the most lethal diseases worldwide. Unlike other solid tumors, pancreatic cancer harbors ample stromal cells and abundant extracellular matrix but lacks vascularization, resulting in persistent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Jinxin, Yang, Gang, Zhou, Wenchuan, Qiu, Jiangdong, Chen, Guangyu, Luo, Wenhao, Zhao, Fangyu, You, Lei, Zheng, Lianfang, Zhang, Taiping, Zhao, Yupei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805044/ https://www.ncbi.nlm.nih.gov/pubmed/33436044 http://dx.doi.org/10.1186/s13045-020-01030-w

Ejemplares similares

Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory
por: Luo, Wenhao, et al.
Publicado: (2020)

Comprehensive Analysis of Autophagy-Associated lncRNAs Reveal Potential Prognostic Prediction in Pancreatic Cancer
por: Chen, Guangyu, et al.
Publicado: (2021)

Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?
por: Luo, Wenhao, et al.
Publicado: (2019)

Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic Cancer
por: Chen, Guangyu, et al.
Publicado: (2022)

Role of the microbiome in occurrence, development and treatment of pancreatic cancer
por: Wang, Yicheng, et al.
Publicado: (2019)

Novel therapies targeting hypoxia mechanism to treat pancreatic cancer
por: Luo, Wenhao, et al.
Publicado: (2021)

Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications
por: Qiu, Jiangdong, et al.
Publicado: (2018)

The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
por: Fu, Yibo, et al.
Publicado: (2021)

Expression, function and clinical application of stanniocalcin‐1 in cancer
por: Zhao, Fangyu, et al.
Publicado: (2020)

PRKRA promotes pancreatic cancer progression by upregulating MMP1 transcription via the NF-κB pathway
por: Qiu, Jiangdong, et al.
Publicado: (2023)

Current epidemiology of pancreatic cancer: Challenges and opportunities
por: Luo, Wenhao, et al.
Publicado: (2020)

LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
por: Feng, Mengyu, et al.
Publicado: (2018)

Novel Discoveries Targeting Pathogenic Gut Microbes and New Therapies in Pancreatic Cancer: Does Pathogenic E. coli Infection Cause Pancreatic Cancer Progression Modulated by TUBB/Rho/ROCK Signaling Pathway? A Bioinformatic Analysis
por: Luo, Wenhao, et al.
Publicado: (2020)

Is Invagination Anastomosis More Effective in Reducing Clinically Relevant Pancreatic Fistula for Soft Pancreas After Pancreaticoduodenectomy Under Novel Fistula Criteria: A Systematic Review and Meta-Analysis
por: Cao, Zhe, et al.
Publicado: (2020)

MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy
por: Cao, Zhe, et al.
Publicado: (2020)

Cancer-specific survival and metastasis in pancreatic mucinous cystadenocarcinoma: A SEER-based cohort study
por: Wang, Ruobing, et al.
Publicado: (2022)

Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer
por: Xiong, Guangbing, et al.
Publicado: (2019)

Tumor microenvironment participates in metastasis of pancreatic cancer
por: Ren, Bo, et al.
Publicado: (2018)

MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma
por: Xiong, Guangbing, et al.
Publicado: (2018)

Correction to: MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma
por: Xiong, Guangbing, et al.
Publicado: (2021)

MiR-1178 Promotes the Proliferation, G1/S Transition, Migration and Invasion of Pancreatic Cancer Cells by Targeting CHIP
por: Cao, Zhe, et al.
Publicado: (2015)

Chemotherapy and tumor microenvironment of pancreatic cancer
por: Liu, Qiaofei, et al.
Publicado: (2017)

Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207
por: You, Lei, et al.
Publicado: (2018)

PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value
por: Xu, Jianwei, et al.
Publicado: (2016)

Metabolism of pancreatic cancer: paving the way to better anticancer strategies
por: Qin, Cheng, et al.
Publicado: (2020)

Analysis of clinical characteristics and treatment of pancreatic cystic tumors
por: You, Lei, et al.
Publicado: (2016)

CHIP: A new modulator of human malignant disorders
por: Cao, Zhe, et al.
Publicado: (2016)

Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine
por: Yu, Yiqi, et al.
Publicado: (2021)

Pancreatic panniculitis associated with pancreatic carcinoma: A case report
por: Zhang, Guannan, et al.
Publicado: (2016)

MicroRNA-27a (miR-27a) in Solid Tumors: A Review Based on Mechanisms and Clinical Observations
por: Zhang, Jingcheng, et al.
Publicado: (2019)

MicroRNA-381—A Key Transcriptional Regulator: Its Biological Function and Clinical Application Prospects in Cancer
por: Zeng, Xue, et al.
Publicado: (2020)

Localized Autoimmune Pancreatitis: Report of a Case Clinically Mimicking Pancreatic Cancer and a Literature Review
por: Cao, Zhe, et al.
Publicado: (2015)

Hypoxic microenvironment induced spatial transcriptome changes in pancreatic cancer
por: Sun, Huizhi, et al.
Publicado: (2021)

The regulation of immune checkpoints by the hypoxic tumor microenvironment
por: Hu, Min, et al.
Publicado: (2021)

Meta-analysis of robotic versus open pancreaticoduodenectomy in all patients and pancreatic cancer patients
por: Fu, Yibo, et al.
Publicado: (2022)

Comparison of long-term benefits of organ-preserving pancreatectomy techniques for benign or low-grade malignant tumors at the pancreatic head
por: Li, Yatong, et al.
Publicado: (2017)

CHIP is a novel tumor suppressor in pancreatic cancer and inhibits tumor growth through targeting EGFR
por: Wang, Tianxiao, et al.
Publicado: (2014)

Tumor Dormancy and Interplay with Hypoxic Tumor Microenvironment
por: Butturini, Elena, et al.
Publicado: (2019)

Exosome-orchestrated hypoxic tumor microenvironment
por: Meng, Wanrong, et al.
Publicado: (2019)

miR-497 expression, function and clinical application in cancer
por: Yang, Gang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0r7fcachva2figviteg3glehvn